NURIX THERAPEUTICS, INC.: accounts_receivable
| Value | {"amount": 2537000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2021-05-31) |
| Status | current |
| Entity | NURIX THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:43:20.797219+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/7ae72159-d000-483b-b823-76436cbf06bd
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-036448 · Open the official SEC filing →Retrieved: 2026-08-19T15:43:20.797219+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001549595/accounts-receivable/2021-05-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/7ae72159-d000-483b-b823-76436cbf06bd
History
- no predecessors — first report